HTC-19 Profile: What’s Cooking in the mRNA Lab?
Jonathan Maurer of the University of Geneva discusses his work with Sanofi and Waters – and why good analytical science has a lot in common with good cooking
False
Jonathan Maurer of the University of Geneva discusses his work with Sanofi and Waters – and why good analytical science has a lot in common with good cooking
False
False
December 1, 2014
0 min read
Upstream processes in biopharma manufacturing are growing ever more efficient; conversely, downstream processing is increasingly a bottleneck. Can a new generation of chromatography techniques and technologies get things moving again?
April 2, 2025
5 min read
Off-the-shelf allogeneic CAR-Ts, increased manufacturing productivity led by digital systems, and more; we ask experts about the future of advanced medicine.
April 7, 2025
6 min read
Meet one company and its new drug candidate in the fight against gram-negative bacterial infections.
March 3, 2025
5 min read
From the GSK boardroom to the White House, and now the board of Abzena, the career path of Moncef Slaoui has resulted in billions of doses of lifesaving vaccines. Here he shares his story.
False
Affiliations:
Specialties:
Areas of Expertise:
5 Topic Commentaries
HTC-19 Profile: What’s Cooking in the mRNA Lab?
Andrew Pekosz, PhD
Molecular Microbiology and Immunology
•Johns Hopkins Bloomberg School of Public Health
Jeff Coller, PhD
RNA biology and therapeutics
•Johns Hopkins University School of Medicine
Melanie Swift, MD
Vaccination programs and public health
•Mayo Clinic
Tal Zaks, MD
mRNA therapeutics and vaccines
•Moderna
Daniel G. Anderson, PhD
Drug delivery and nucleic acid therapeutics
•Massachusetts Institute of Technology
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.